Steve Kirsch's newsletter

Steve Kirsch's newsletter

Why you should avoid Ozempic, Mounjaro, etc.

Elon Musk's Mounjaro weight loss story is getting a lot of play. In this article, I'll reveal what they aren't telling you that you need to know. It may change your opinion on these drugs.

Steve Kirsch's avatar
Steve Kirsch
Dec 26, 2024
∙ Paid

Executive summary

I’ve had doctors tell me how effective Mounjaro is for weight loss. And now an Elon Musk story pops up.

In this article, I’ll tell you the 3 most important things they NEVER tell you about these “wonder” drugs.

This information could save your life. Two of them are life-threatening.

If you are considering taking a GLP-1 inhibitor like Ozempic, Mounjaro (aka Tirzepatide or Zepbound), etc. this article is a must read.

I’ll show you why the benefits aren’t what you’ve been led to believe and how they downplay the risks.

Bottom line: I’d never take these drugs and I don’t think you should either.

Here’s the evidence and what they are hiding.

And I’ll tell you what I do for weight loss that is easy to execute on and that works. And it doesn’t have any of the downsides.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Steve Kirsch · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture